AlpInvest Partners’s Guardant Health GH Stock Holding History

AlpInvest Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42,652	Closed	-$3.46M	–	14
2020 Q2	$3.46M	Sell	42,652 -63,978	-60%	-$5.15M	7.32%	4
2020 Q1	$7.39M	Buy	106,630 +31,989	+43%	+$2.45M	8.36%	6
2019 Q4	$5.83M	Buy	74,641 +10,663	+17%	+$768K	4.96%	7
2019 Q3	$4.08M	Buy	+63,978	New	+$5.64M	5.03%	8

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

AlpInvest Partners's GH Position: Q3 2020 in Review

AlpInvest Partners sold out of Guardant Health (GH) in Q3 2020, closing a stake of 42,652 shares — an estimated $3.46M sold.

AlpInvest Partners first reported a position in GH in Q3 2019 and held it in 4 quarters. The position peaked at $7.39M in Q1 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

AlpInvest Partners reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
AlpInvest Partners sold 42,652 Guardant Health shares in Q3 2020, an estimated $3.46M.
AlpInvest Partners first reported a position in Guardant Health in Q3 2019 and held it in 4 quarters.
AlpInvest Partners's Guardant Health position peaked at $7.39M in Q1 2020.
346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on AlpInvest Partners's 13F filing for Q3 2020, filed 13 Nov 2020.